Dark mode is part of the Premium plan.

It is included in the free trial.

Sign inSee Premium
Create a free account
Create a free account

Feeds › Patents

Patents

New US patents granted to public companies.

About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Source and freshness · Information, not investment advice (disclaimer).

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker AVIR

Latest patent grants
GrantedPatentOwnerTypeSource
Nov 3, 202612778975
Advantageous anti-HCV combination therapy
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 29, 202612746251
NiRAN interfering drugs for SARS-CoV-2 mutant therapy
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 22, 202612741984
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jul 21, 202612686697
Advantageous morphic form of AT-527 hemi-sulfate salt
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jun 2, 202612642771
Compositions comprising PGI2-receptor agonists and processes for the…
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Feb 24, 202612559462
Pyrimidine derivatives as modulators of the 5-HT2A serotonin receptor…
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Feb 17, 202612551499
Highly active compounds against COVID-19
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 25, 202512479813
Method of therapeutically treating cancer
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 4, 202512458656
Advantageous anti-HCV combination therapy
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 7, 202512433865
Compositions comprising PGI2-receptor agonists and processes for the…
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 5, 202512378198
Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluorome…
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 5, 202512377071
Methods of treating conditions related to the S1P1 receptor
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 5, 202512377067
Methods of treating PAH with combinations of ralinepag and other agen…
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Mar 4, 202512239627
Method of treating conditions related to the PGI2 receptor
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Feb 18, 202512226429
Highly active compounds against COVID-19
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Feb 11, 202512220392
Combination composition
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jan 21, 202512201633
Compounds and methods for treatment of visceral pain
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jan 14, 2025RE50267
Modulators of the prostacyclin (PGI2) receptor useful for the treatme…
AVIR
Atea Pharmaceuticals, Inc.
reissueGoogle Patents ↗
Dec 3, 202412156866
Methods of treating conditions related to the S1P1 receptor
AVIR
Atea Pharmaceuticals, Inc.
utilityGoogle Patents ↗

19 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:50 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances